FDA Expands Meningitis Notification ListThursday, October 18, 2012
Last week, the OSMA reported on the meningitis outbreak as a result of contaminated medications coming from the New England Compounding Center (NECC). The FDA has expanded the list of medications in which they’re requesting physician follow up due to new infections that have been reported. Practices are asked to contact any patient who may have received an injectable drug or cardioplegic solution after May 21, 2012, that was compounded at NECC and counsel patients on possible symptoms related to the specific procedure that the patient had. If a patient develops symptoms, he or she needs to seek medical attention immediately. If a physician sees any unusual infections that might be related to receiving a product from NECC, he or she also needs to report those cases to the MedWatch program and the local health department. For more information, click here.
Want to continue the discussion on the OSMA Community? Click here to post your thoughts and connect with your peers on the OSMA’s member-only forum.